How much funding has HAWAII BIOTECH, INC. raised?

HAWAII BIOTECH, INC. has raised $9.7M in total funding, most recently a grant round.

Who are HAWAII BIOTECH, INC.'s investors?

HAWAII BIOTECH, INC.'s investors include Merck & Co..

When was HAWAII BIOTECH, INC. founded?

HAWAII BIOTECH, INC. was founded in 2015.

Where is HAWAII BIOTECH, INC. headquartered?

HAWAII BIOTECH, INC. is headquartered in HONOLULU, Hawaii, United States.

What industry is HAWAII BIOTECH, INC. in?

HAWAII BIOTECH, INC. operates in Biotech, Healthcare.

HAWAII BIOTECH, INC.

Acquired

Home - HBI

HONOLULU, United States · Founded 2015 · $9.7M raised

Biotech

Healthcare

Headquarters: HONOLULU, Hawaii
Founded: 2015
Business Model: B2G
Website: hibiotech.com

Total Funding: $9.7M
Last Round: $680K GrantApr 2020
Rounds: 3

About

Hawaii Biotech is a privately held biotechnology company developing recombinant subunit protein vaccines for established and emerging infectious diseases including West Nile virus, Zika, Chikungunya, and tick-borne flaviviruses. The company's stable insect cell vaccine platform produces high-quality proteins that elicit strong immune responses, supported by its proprietary semi-synthetic saponin adjuvant GPI-0100. Hawaii Biotech also develops small molecule drug candidates targeting anthrax intoxication and botulism.

Summary

HAWAII BIOTECH, INC. is a Biotech company based in HONOLULU, United States, founded in 2015. It has raised $9.7M in total across 3 rounds, most recently a $680K Grant round in Apr 2020. Investors include Merck & Co..